Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Jacks, T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 132 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zhang, ZQ; Wang, Y; Vikis, HG; Johnson, L; Liu, GJ; Li, J; Anderson, MW; Sills, RC; Hong, HL; Devereux, TR; Jacks, T; Guan, KL; You, M
      Wildtype Kras2 can inhibit lung carcinogenesis in mice

      NATURE GENETICS
    2. DePinho, RA; Jacks, T
      Tumor induction in suppressor gene knockout mice - Introduction

      SEMINARS IN CANCER BIOLOGY
    3. Reilly, KM; Jacks, T
      Genetically engineered mouse models of astrocytoma: GEMs in the rough?

      SEMINARS IN CANCER BIOLOGY
    4. Zhou, CY; Guo, LQ; Morriello, G; Pasternak, A; Pan, YP; Rohrer, SP; Birzin, ET; Huskey, SEW; Jacks, T; Schleim, KD; Cheng, K; Schaeffer, JM; Patchett, AA; Yang, LH
      Nipecotic and iso-nipecotic amides as potent and selective somatostatin subtype-2 receptor agonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    5. Tuveson, DA; Willis, NA; Jacks, T; Griffin, JD; Singer, S; Fletcher, CDM; Fletcher, JA; Demetri, GD
      STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

      ONCOGENE
    6. Lipinski, MM; Macleod, KF; Williams, BO; Mullaney, TL; Crowley, D; Jacks, T
      Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system

      EMBO JOURNAL
    7. Cichowski, K; Jacks, T
      NF1 tumor suppressor gene function: Narrowing the GAP

      CELL
    8. Johnson, L; Mercer, K; Greenbaum, D; Bronson, RT; Crowley, D; Tuveson, DA; Jacks, T
      Somatic activation of the K-ras oncogene causes early onset lung cancer inmice

      NATURE
    9. Geng, Y; Yu, QY; Whoriskey, W; Dick, F; Tsai, KY; Ford, HL; Biswas, DK; Pardee, AB; Amati, B; Jacks, T; Richardson, A; Dyson, N; Sicinski, P
      Expression of cyclins E1 and E2 during mouse development and in neoplasia

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    10. Boyd, SD; Tsai, KY; Jacks, T
      An intact HDM2 RING-finger domain is required for nuclear exclusion of p53

      NATURE CELL BIOLOGY
    11. Birnbaum, RA; O'Marcaigh, A; Wardak, Z; Zhang, YY; Dranoff, G; Jacks, T; Clapp, DW; Shannon, KM
      Nf1 and Gmcsf interact in myeloid leukemogenesis

      MOLECULAR CELL
    12. Reilly, KM; Loisel, DA; Bronson, RT; McLaughlin, ME; Jacks, T
      Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

      NATURE GENETICS
    13. Attardi, LD; Reczek, EE; Cosmas, C; Demicco, EG; McCurrach, ME; Lowe, SW; Jacks, T
      PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family

      GENES & DEVELOPMENT
    14. Sage, J; Mulligan, GJ; Attardi, LD; Miller, A; Chen, SQ; Williams, B; Theodorou, E; Jacks, T
      Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization

      GENES & DEVELOPMENT
    15. Attardi, LD; Reczek, EE; Cosmas, C; Demicco, EG; McCurrach, ME; Lowe, SW; Jacks, T
      PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family (vol 14, pg 704, 2000)

      GENES & DEVELOPMENT
    16. Lim, DJ; Rubenstein, AE; Evans, DG; Jacks, T; Seizinger, BG; Baser, ME; Beebe, D; Brackmann, DE; Chiocca, EA; Fehon, RG; Giovannini, M; Glazer, R; Gusella, JF; Gutmann, DH; Korf, B; Lieberman, F; Martuza, R; McClatchey, AI; Parry, DM; Pulst, SM; Ramesh, V; Ramsey, WJ; Ratner, N; Rutkowski, JL; Ruttledge, M; Weinstein, DE
      Advances in neurofibromatosis 2 (NF2): A workshop report

      JOURNAL OF NEUROGENETICS
    17. Irwin, M; Marin, MC; Phillips, AC; Seelan, RS; Smith, DI; Liu, WG; Flores, ER; Tsai, KY; Jacks, T; Vousden, KH; Kaelin, WG
      Role for the p53 homologue p73 in E2F-1-induced apoptosis

      NATURE
    18. Zhang, Y; Griffith, EC; Sage, J; Jacks, T; Liu, JO
      Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21(WAF1/CIP1)

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    19. Wang, YH; Hayward, SW; Donjacour, AA; Young, P; Jacks, T; Sage, J; Dahiya, R; Cardiff, RD; Day, ML; Cunha, GR
      Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue

      CANCER RESEARCH
    20. Attardi, LD; Jacks, T
      The role of p53 in tumour suppression: lessons from mouse models

      CELLULAR AND MOLECULAR LIFE SCIENCES
    21. DePinho, RA; Jacks, T
      A bumper crop of cancer genes

      NATURE GENETICS
    22. Pasternak, A; Pan, YP; Marino, D; Sanderson, PE; Mosley, R; Rohrer, SP; Birzin, ET; Huskey, SEW; Jacks, T; Schleim, KD; Cheng, K; Schaeffer, JM; Patchett, AA; Yang, LH
      Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    23. Yang, LH; Morriello, G; Leung, K; Jacks, T; Cheng, K; Schleim, KD; Smith, R; Patchett, AA
      Thiazole-derived potent, highly bioavailable short duration growth hormonesecretagogues

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    24. Deshaies, RJ; Jacks, T
      Cell multiplication - Peering in and peering out: regulation of and by thecell cycle

      CURRENT OPINION IN CELL BIOLOGY
    25. Lipinski, MM; Jacks, T
      The retinoblastoma gene family in differentiation and development

      ONCOGENE
    26. DePinho, RA; Jacks, T
      Mouse models of cancer - Introductory comments

      ONCOGENE
    27. Tuveson, DA; Jacks, T
      Modeling human lung cancer in mice: similarities and shortcomings

      ONCOGENE
    28. de Lange, T; Jacks, T
      For better or worse? Telomerase inhibition and cancer

      CELL
    29. Cichowski, K; Shih, TS; Schmitt, E; Santiago, S; Reilly, K; McLaughlin, ME; Bronson, RT; Jacks, T
      Mouse models of tumor development in neurofibromatosis type 1

      SCIENCE
    30. Brugarolas, J; Moberg, K; Boyd, SD; Taya, Y; Jacks, T; Lees, JA
      Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G(1) arrest after gamma-irradiation

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    31. Macleod, KF; Jacks, T
      Insights into cancer from transgenic mouse models

      JOURNAL OF PATHOLOGY
    32. Zhou, XZ; Wong, S; Walter, J; Jacks, T; Eisen, HN
      Increased generation of CD8(+) T cell clones in p53 mutant mice

      JOURNAL OF IMMUNOLOGY
    33. Schleim, KD; Jacks, T; Cunningham, P; Feeney, W; Frazier, EG; Niebauer, GW; Zhang, D; Chen, H; Smith, RG; Hickey, G
      Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation

      ENDOCRINOLOGY
    34. Mahgoub, N; Taylor, BR; Gratiot, M; Kohl, NE; Gibbs, JB; Jacks, T; Shannon, KM
      In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells

      BLOOD
    35. Mahgoub, N; Taylor, BR; Le Beau, MM; Gratiot, M; Carlson, KM; Atwater, SK; Jacks, T; Shannon, KM
      Myeloid malignancies induced by alkylating agents in Nf1 mice

      BLOOD
    36. TSAI KY; HU YW; MACLEOD KF; CROWLEY D; YAMASAKI L; JACKS T
      MUTATION OF E2F-1 SUPPRESSES APOPTOSIS AND INAPPROPRIATE S-PHASE ENTRY AND EXTENDS SURIVAL OF RB-DEFICIENT MOUSE EMBRYOS

      MOLECULAR CELL
    37. YAMASAKI L; BRONSON R; WILLIAMS BO; DYSON NJ; HARLOW E; JACKS T
      LOSS OF E2F-1 REDUCES TUMORIGENESIS AND EXTENDS THE LIFE-SPAN OF RB1(+ -)MICE/

      Nature genetics
    38. SHAW RJ; HENRY M; SOLOMON F; JACKS T
      RHOA-DEPENDENT PHOSPHORYLATION AND RELOCALIZATION OF ERM PROTEINS INTO APICAL MEMBRANE ACTIN PROTRUSIONS IN FIBROBLASTS/

      Molecular biology of the cell
    39. SHAW RJ; MCCLATCHEY AI; JACKS T
      LOCALIZATION AND FUNCTIONAL DOMAINS OF THE NEUROFIBROMATOSIS TYPE-II TUMOR-SUPPRESSOR, MERLIN

      Cell growth & differentiation
    40. NACHT M; JACKS T
      V(D)J RECOMBINATION IS NOT REQUIRED FOR THE DEVELOPMENT OF LYMPHOMA IN P53-DEFICIENT MICE

      Cell growth & differentiation
    41. YANG LH; MORRIELLO G; PRENDERGAST K; CHENG K; JACKS T; CHAN WWS; SCHLEIM KD; SMITH RG; PATCHETT AA
      POTENT 3-SPIROPIPERIDINE GROWTH-HORMONE SECRETAGOGUES

      Bioorganic & medicinal chemistry letters
    42. MCCLATCHEY AI; JACKS T
      TUMOR-SUPPRESSOR MUTATIONS IN MICE - THE NEXT-GENERATION

      Current opinion in genetics & development
    43. MCCLATCHEY AI; SAOTOME I; MERCER K; CROWLEY D; GUSELLA JF; BRONSON RT; JACKS T
      MICE HETEROZYGOUS FOR A MUTATION AT THE NF2 TUMOR-SUPPRESSOR LOCUS DEVELOP A RANGE OF HIGHLY METASTATIC TUMORS

      Genes & development
    44. XU Y; YANG EM; BRUGAROLAS J; JACKS T; BALTIMORE D
      INVOLVEMENT OF P53 AND P21 IN CELLULAR DEFECTS AND TUMORIGENESIS IN ATM(- -) MICE/

      Molecular and cellular biology
    45. LANNI JS; JACKS T
      CHARACTERIZATION OF THE P53-DEPENDENT POSTMITOTIC CHECKPOINT FOLLOWING SPINDLE DISRUPTION

      Molecular and cellular biology
    46. MULLIGAN GJ; WONG J; JACKS T
      P130 IS DISPENSABLE IN PERIPHERAL T-LYMPHOCYTES - EVIDENCE FOR FUNCTIONAL COMPENSATION BY P107 AND PRB

      Molecular and cellular biology
    47. MULLIGAN G; JACKS T
      THE RETINOBLASTOMA GENE FAMILY - COUSINS WITH OVERLAPPING INTERESTS

      Trends in genetics
    48. JACKS T; WEINBERG RA
      THE EXPANDING ROLE OF CELL-CYCLE REGULATORS

      Science
    49. ZAMBLE DB; JACKS T; LIPPARD SJ
      P53-DEPENDENT AND -INDEPENDENT RESPONSES TO CISPLATIN IN MOUSE TESTICULAR TERATOCARCINOMA CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    50. YANG LH; MORRIELLO G; PATCHETT AA; LEUNG K; JACKS T; CHENG K; SCHLEIM KD; FEENEY W; CHAN WWS; CHIU SHL; SMITH RG
      3-YL)PROPIONYL]-3-BENZYLPIPERIDINE-3(S)-CARBOXYLIC ACID ETHYL-ESTER (L-163,540) - A POTENT, ORALLY BIOAVAILABLE, AND SHORT-DURATION GROWTH-HORMONE SECRETAGOGUE

      Journal of medicinal chemistry
    51. ZHANG YY; VIK TA; RYDER JW; SROUR EF; JACKS T; SHANNON K; CLAPP DW
      NF1 REGULATES HEMATOPOIETIC PROGENITOR-CELL GROWTH AND RAS SIGNALING IN RESPONSE TO MULTIPLE CYTOKINES

      The Journal of experimental medicine
    52. BRUGAROLAS J; BRONSON RT; JACKS T
      P21 IS A CRITICAL CDK2 REGULATOR ESSENTIAL FOR PROLIFERATION CONTROL IN RB-DEFICIENT CELLS

      The Journal of cell biology
    53. SHAW RJ; MCCLATCHEY AI; JACKS T
      REGULATION OF THE NEUROFIBROMATOSIS TYPE-2 TUMOR-SUPPRESSOR PROTEIN, MERLIN, BY ADHESION AND GROWTH ARREST STIMULI

      The Journal of biological chemistry
    54. MACLEOD K; JACKS T
      CONTROL OF HEMATOPOIETIC STEM-CELL RENEWAL AND LINEAGE COMMITMENT BY THE RETINOBLASTOMA TUMOR-SUPPRESSOR GENE

      British Journal of Cancer
    55. BRUGAROLAS J; JACKS T
      DOUBLE INDEMNITY - P53, BRCA AND CANCER

      Nature medicine
    56. LUNA RMD; AMELSE LL; CHAVEZREYES A; EVANS SC; BRUGAROLAS J; JACKS T; LOZANO G
      DELETION OF P21 CAN NOT SUBSTITUTE FOR P53 LOSS IN RESCUE OF MDM2 NULL LETHALITY

      Nature genetics
    57. SILVA AJ; FRANKLAND PW; MAROWITZ Z; FRIEDMAN E; LAZLO G; CIOFFI D; JACKS T; BOURTCHULADZE R
      A MOUSE MODEL FOR THE LEARNING AND MEMORY DEFICITS ASSOCIATED WITH NEUROFIBROMATOSIS TYPE-I

      Nature genetics
    58. JONES JM; ATTARDI L; GODLEY LA; LAUCIRICA R; MEDINA D; JACKS T; VARMUS HE; DONEHOWER LA
      ABSENCE OF P53 IN A MOUSE MAMMARY-TUMOR MODEL PROMOTES TUMOR-CELL PROLIFERATION WITHOUT AFFECTING APOPTOSIS

      Cell growth & differentiation
    59. JOHNSON L; GREENBAUM D; CICHOWSKI K; MERCER K; MURPHY E; SCHMITT E; BRONSON RT; UMANOFF H; EDELMANN W; KUCHERLAPATI R; JACKS T
      K-RAS IS AN ESSENTIAL GENE IN THE MOUSE WITH PARTIAL FUNCTIONAL OVERLAP WITH N-RAS (VOL 11, PG 2468, 1997)

      Genes & development
    60. JOHNSON L; GREENBAUM D; CICHOWSKI K; MERCER K; MURPHY E; SCHMITT E; BRONSON RT; UMANOFF H; EDELMANN W; KUCHERLAPATI R; JACKS T
      K-RAS IS AN ESSENTIAL GENE IN THE MOUSE WITH PARTIAL FUNCTIONAL OVERLAP WITH N-RAS

      Genes & development
    61. MCCLATCHEY AI; SAOTOME I; RAMESH V; GUSELLA JF; JACKS T
      THE NF2 TUMOR-SUPPRESSOR GENE-PRODUCT IS ESSENTIAL FOR EXTRAEMBRYONICDEVELOPMENT IMMEDIATELY PRIOR TO GASTRULATION

      Genes & development
    62. VANDERGEER P; HENKEMEYER M; JACKS T; PAWSON T
      ABERRANT RAS REGULATION AND REDUCED P190 TYROSINE PHOSPHORYLATION IN CELLS LACKING P120-GAP

      Molecular and cellular biology
    63. LOWE SW; JACKS T
      P53 AND TREATMENT OF BLADDER-CANCER - REPLY

      Nature
    64. COLLINS K; JACKS T; PAVLETICH NP
      THE CELL-CYCLE AND CANCER

      Proceedings of the National Academy of Sciences of the United Statesof America
    65. LANNI JS; LOWE SW; LICITRA EJ; LIU JO; JACKS T
      P53-INDEPENDENT APOPTOSIS INDUCED BY PACLITAXEL THROUGH AN INDIRECT MECHANISM

      Proceedings of the National Academy of Sciences of the United Statesof America
    66. MAHGOUB N; TAYLOR B; LEBEAU H; GRATIOT M; CARLSON K; JACKS T; SHANNON KM
      A MOUSE MODEL OF ALKYLATOR-INDUCED LEUKEMIA

      Blood
    67. BIRNBAUM R; OMARCAIGH A; WARDAK Z; ZHANG Y; DRANOFF G; JACKS T; CLAPP DW; SHANNON KM
      INTERACTION BETWEEN NF1 AND GMCSF IN LEUKEMOGENESIS AND HEMATOPOIETICENGRAFTMENT

      Blood
    68. ZHANG YY; VIK TA; RYDER JW; SROUR EA; JACKS T; SHANNON K; CLAPP DW
      LOSS OF THE MURINE HOMOLOG OF NF1 (NF1) RESULTS IN ABERRANT MAP KINASE-ACTIVITY IN RESPONSE TO MULTIPLE CYTOKINES IN PRIMITIVE PRIMARY PROGENITOR CELLS

      Blood
    69. MAHGOUB N; TAYLOR B; GRATIOT M; KOHL N; GIBBS J; JACKS T; SHANNON KM
      EFFECTS OF FARNESYL TRANSFERASE INHIBITOR (FTI) L744, 832 IN A RAS-ACTIVATED MURINE MYELOID-LEUKEMIA MODEL

      Blood
    70. BOLLAG G; CLAPP DW; SHIH S; ADLER F; ZHANG YY; THOMPSON P; LANGE BJ; FREEDMAN MH; MCCORMICK F; JACKS T; SHANNON K
      LOSS OF NF1 RESULTS IN ACTIVATION OF THE RAS SIGNALING PATHWAY AND LEADS TO ABERRANT GROWTH IN HEMATOPOIETIC-CELLS (VOL 12, PG 144, 1996)

      Nature genetics
    71. BOLLAG G; CLAPP DW; SHIH S; ADLER F; ZHANG YY; THOMPSON P; LANGE BJ; FREEDMAN MH; MCCORMICK F; JACKS T; SHANNON K
      LOSS OF NF1 RESULTS IN ACTIVATION OF THE RAS SIGNALING PATHWAY AND LEADS TO ABERRANT GROWTH IN HEMATOPOIETIC-CELLS

      Nature genetics
    72. CICHOWSKI K; SHIH TS; JACKS T
      NF1 GENE TARGETING - TOWARD MODELS AND MECHANISMS

      Seminars in cancer biology
    73. WILLIAMS BO; JACKS T
      MECHANISMS OF CARCINOGENESIS AND THE MUTANT MOUSE

      Current opinion in genetics & development
    74. LEHAR SM; NAEHT M; JACKS T; VATER CA; CHITTENDEN T; GUILD BC
      IDENTIFICATION AND CLONING OF EI24, A GENE INDUCED BY P53 IN ETOPOSIDE-TREATED CELLS

      Oncogene
    75. NACHT M; STRASSER A; CHAN YR; HARRIS AW; SCHLISSEL M; BRONSON R; JACKS T
      MUTATIONS IN THE P53 AND SCID GENES COOPERATE IN TUMORIGENESIS

      Genes & development
    76. LEE MH; WILLIAMS BO; MULLIGAN G; MUKAI S; BRONSON RT; DYSON N; HARLOW E; JACKS T
      TARGETED DISRUPTION OF P107 - FUNCTIONAL OVERLAP BETWEEN P107 AND RB

      Genes & development
    77. COBRINIK D; LEE MH; HANNON G; MULLIGAN G; BRONSON RT; DYSON N; HARLOW E; BEACH D; WEINBERG RA; JACKS T
      SHARED ROLE OF THE PRB-RELATED P130 AND P107 PROTEINS IN LIMB DEVELOPMENT

      Genes & development
    78. JACKS T; STRASSER A
      HOT PAPERS - APOPTOSIS - DNA-DAMAGE CAN INDUCE APOPTOSIS IN PROLIFERATING LYMPHOID-CELLS VIA P53-INDEPENDENT MECHANISMS INHIBITABLE BY BCL-2 BY STRASSER,A., HARRIS,A.W., JACKS,T., CORY,S. - COMMENTS

      The Scientist
    79. MACLEOD KF; HU YW; JACKS T
      LOSS OF RB ACTIVATES BOTH P53-DEPENDENT AND INDEPENDENT CELL-DEATH PATHWAYS IN THE DEVELOPING MOUSE NERVOUS-SYSTEM

      EMBO journal
    80. ATTARDI LD; LOWE SW; BRUGAROLAS J; JACKS T
      TRANSCRIPTIONAL ACTIVATION BY P53, BUT NOT INDUCTION OF THE P21 GENE,IS ESSENTIAL FOR ONCOGENE-MEDIATED APOPTOSIS

      EMBO journal
    81. JACKS T
      LESSONS FROM THE P53 MUTANT MOUSE

      Journal of cancer research and clinical oncology
    82. MUKAI S; WILLIAMS BO; MULLIGAN G; MERCER K; JACKS T
      PERSISTENT HYPERPLASTIC PRIMARY VITREOUS IN MICE WITH TARGETED DISRUPTION OF THE P53 GENE

      Investigative ophthalmology & visual science
    83. YAMASAKI L; JACKS T; BRONSON R; GOILLOT E; HARLOW E; DYSON NJ
      TUMOR-INDUCTION AND TISSUE ATROPHY IN MICE LACKING E2F-1

      Cell
    84. JACKS T
      TUMOR-SUPPRESSOR GENE-MUTATIONS IN MICE

      Annual review of genetics
    85. JACKS T; WEINBERG RA
      CELL-CYCLE CONTROL AND ITS WATCHMAN

      Nature
    86. GRAEBER TG; OSMANIAN C; JACKS T; HOUSMAN DE; KOCH CJ; LOWE SW; GIACCIA AJ
      HYPOXIA-MEDIATED SELECTION OF CELLS WITH DIMINISHED APOPTOTIC POTENTIAL IN SOLID TUMORS

      Nature
    87. NOVITCH BG; MULLIGAN GJ; JACKS T; LASSAR AB
      SKELETAL-MUSCLE CELLS LACKING THE RETINOBLASTOMA PROTEIN DISPLAY DEFECTS IN MUSCLE GENE-EXPRESSION AND ACCUMULATE IN S-PHASES AND G(2)-PHASES OF THE CELL-CYCLE

      The Journal of cell biology
    88. JACKS T; SMITH R; JUDITH F; SCHLEIM K; FRAZIER E; CHEN H; KRUPA D; HORA D; NARGUND R; PATCHETT A; HICKEY G
      MK-0677, A POTENT, NOVEL, ORALLY-ACTIVE GROWTH-HORMONE (GH) SECRETAGOGUE - GH, INSULIN-LIKE GROWTH-FACTOR-I, AND OTHER HORMONAL RESPONSES IN BEAGLES

      Endocrinology
    89. ZHANG YY; SROUR E; SHANNON K; JACKS T; CLAPP DW
      LOSS OF THE MURINE HOMOLOG OF NF1 (NF1) RESULTS IN ALTERATION OF MYELOID CELL CONTROL IN BOTH PRIMITIVE AND LINEAGE RESTRICTED PRIMARY PROGENITOR CELLS

      Blood
    90. SAH VP; ATTARDI LD; MULLIGAN GJ; WILLIAMS BO; BRONSON RT; JACKS T
      A SUBSET OF P53-DEFICIENT EMBRYOS EXHIBIT EXENCEPHALY

      Nature genetics
    91. TISCHLER AS; SHIH TS; WILLIAMS BO; JACKS T
      CHARACTERIZATION OF PHEOCHROMOCYTOMAS IN A MOUSE STRAIN WITH A TARGETED DISRUPTIVE MUTATION OF THE NEUROFIBROMATOSIS GENE NF1

      Endocrine pathology
    92. MACLEOD KF; SHERRY N; HANNON G; BEACH D; TOKINO T; KINZLER K; VOGELSTEIN B; JACKS T
      P53-DEPENDENT AND INDEPENDENT EXPRESSION OF P21 DURING CELL-GROWTH, DIFFERENTIATION, AND DNA-DAMAGE

      Genes & development
    93. JACKS T
      EXAMINATION OF TUMOR-SUPPRESSOR GENE-FUNCTION USING GENE TARGETING INTHE MOUSE

      Journal of cellular biochemistry
    94. SAWYERS CL; GOGA A; XUAN L; HAMBUCH T; SENECHAL K; JACKS T; BERK A; WITTE ON
      THE C-ABL NUCLEAR TYROSINE KINASE BINDS TO THE P53 TUMOR-SUPPRESSOR PROTEIN AND SUPPRESSES GROWTH IN A P53 DEPENDENT FASHION

      Journal of cellular biochemistry
    95. HENKEMEYER M; ROSSI DJ; HOLMYARD DP; PURI MC; MBAMALU G; HARPAL K; SHIH TS; JACKS T; PAWSON T
      VASCULAR SYSTEM DEFECTS AND NEURONAL APOPTOSIS IN MICE LACKING RAS GTPASE-ACTIVATING PROTEIN

      Nature
    96. BRUGAROLAS J; CHANDRASEKARAN C; GORDON JI; BEACH D; JACKS T; HANNON GJ
      RADIATION-INDUCED CELL-CYCLE ARREST COMPROMISED BY P21 DEFICIENCY

      Nature
    97. MOMBAERTS P; TERHORST C; JACKS T; TONEGAWA S; SANCHO J
      CHARACTERIZATION OF IMMATURE THYMOCYTE LINES DERIVED FROM T-CELL RECEPTOR OR RECOMBINATION ACTIVATING GENE-1 AND P53 DOUBLE MUTANT MICE

      Proceedings of the National Academy of Sciences of the United Statesof America
    98. PATCHETT AA; NARGUND RP; TATA JR; CHEN MH; BARAKAT KJ; JOHNSTON DBR; CHENG K; CHAN WWS; BUTLER B; HICKEY G; JACKS T; SCHLEIM K; PONG SS; CHAUNG LYP; CHEN HY; FRAZIER E; LEUNG KH; CHIU SHL; SMITH RG
      DESIGN AND BIOLOGICAL-ACTIVITIES OF L-163,191 (MK-0677) - A POTENT, ORALLY-ACTIVE GROWTH-HORMONE SECRETAGOGUE

      Proceedings of the National Academy of Sciences of the United Statesof America
    99. TISCHLER AS; JACKS T; SHIH TS; WILLIAMS BO
      CHARACTERIZATION OF PHEOCHROMOCYTOMAS IN A MOUSE STRAIN WITH A MUTATION OF THE NEUROFIBROMATOSIS GENE NF1

      Laboratory investigation
    100. BOLLAG G; CLAPP DW; SHIH S; ADLER F; ZHANG Y; THOMPSON P; LANGE BJ; FREEDMAN MH; MCCORMICK F; JACKS T; SHANNON KM
      LOSS OF NF1 RESULTS IN ACTIVATION OF THE RAS SIGNALING PATHWAY AND LEADS TO ABERRANT GROWTH IN MURINE AND HUMAN HEMATOPOIETIC-CELLS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 06:18:55